Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were taking cholesterol-lowering statin ...

Experts analysed 14 previous studies involving more than 100,000 patients at very high risk of a heart attack or stroke, or ...

A JAMA Internal Medicine study published April 7 examined the effects of changing the default prescription lengths for ...

A new study from the University of Pennsylvania’s Perelman School of Medicine shows that making 90-day prescriptions the default option in the electronic health system led to thousands more patients ...

With a simple click, doctors can potentially save lives and reduce heart attack and stroke risks for thousands of patients by helping them have their statins on hand.

Cholesterol experts at the British Heart Foundation say two foods can lower cholesterol levels in similar ways to how statins ...

An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

Alzheimer’s disease and other dementias “don’t just suddenly descend on us when we are old”, says James Rowe, professor of ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.